Category
Cognitive support
50 plain-language articles on cognitive support — the physiology, the compounds, and what the evidence actually shows.
50 articles
Brain fog that comes and goesSome days the words are there. Other days there's a half-second pause where the noun should be, the sentence reroutes around it, and you spend the rest of the conversation hoping no one noticed. Some weeks you read a paragraph three times before it lands. Then it lifts. The good days return. Then it comes back. Brain fog that comes and goes isn't random, and it isn't in your head in the dismissive sense. It's a real physiological state, and its on-off pattern is the most useful diagnostic clue it gives you.8 min readWhat people are reporting about AdamaxThis article summarizes experiences reported in public online communities including Reddit, longevity forums, and discussion boards. We are not advocating human use of any compound discussed here. Many of the peptides discussed are not FDA-approved for the uses described, and some are explicitly not approved for human or veterinary use. What follows is a synthesis of what people have reported, presented to give readers context on the public conversation — not as guidance, not as evidence of safety or efficacy, and not as a recommendation. Decisions about any compound should be made with a qualified prescribing provider after a full medical evaluation.8 min readAdamax — the enhanced Semax analogYou've read the Semax research. The BDNF upregulation is compelling. The Russian clinical data on stroke recovery and cognitive enhancement is more substantial than you expected. The intranasal delivery makes practical sense. And then you get to the pharmacokinetics section and find the number that gives you pause: the half-life of Semax after intranasal administration is measured in minutes. The molecule is active, bioavailable via the olfactory route, and then degraded quickly by peptidases in the blood and tissues. Whatever it's doing, it's doing it briefly, and the dosing implications — multiple administrations per day, careful timing around the desired effect window — are a practical constraint on a compound that's already operating outside the mainstream pharmaceutical supply chain.8 min readAnxiety that wasn't there a year agoYou've managed difficult things without your body turning against you. Job losses, relationship endings, health scares, the accumulated weight of a life with no shortage of hard passages. You're not someone who catastrophizes. You've always been able to sit with uncertainty without it becoming a physical event. So when the heart racing at rest started — or the sense of dread that didn't attach to anything specific, or waking at 4 a.m. with your body braced for something that isn't there — you noticed it was different. Not anxiety the way you understood anxiety. Something running without content. Your nervous system in a state of readiness with no object to be ready for.8 min readBDNF — the brain growth factor that links exercise to cognitionIn the early 1990s, researchers at the Salk Institute were trying to understand why running wheels in rat cages did anything to the brain at all. The behavioral observation was already established — rats with access to running wheels performed better on maze tasks, showed better stress resilience, had measurably different neural architecture in the hippocampus. The question was mechanism. What was happening in the tissue that exercise could possibly cause? The answer they kept arriving at was a protein that most of the neuroscience community hadn't been thinking much about: brain-derived neurotrophic factor.11 min readBDNF and the exercising brain — the neurotrophin that links movement to memoryIn 1982, a German neuroscientist named Yves-Alain Barde, working with Hans Thoenen at the Max Planck Institute, purified a tiny amount of a protein from pig brain that could keep certain neurons alive in a dish — neurons that would otherwise have died. It was a painstaking effort; the protein was present in vanishingly small quantities, and isolating enough to characterize took the better part of a decade of refinement. They named it brain-derived neurotrophic factor. At the time it looked like a narrow curiosity: a second member of a small family of survival factors, the first of which, nerve growth factor, had won Rita Levi-Montalcini and Stanley Cohen the Nobel Prize. What no one fully anticipated was that this second molecule would turn out to be one of the most important signals in the brain — the molecular bridge between how the body moves and how the mind learns, remembers, and feels.8 min readThe brain fog that follows your cycle — the cognitive fluctuation no one mapped for youThere are days in the month when your mind is a precision instrument. You write fast, you hold the thread of a conversation without losing it, you do mental math in real time and the answer is there before you need it. You feel, in some basic cognitive sense, like yourself. And then there are other days — often predictable days, often a particular cluster of days — when you sit down to write the same kind of thing and the words are not there. Not gone exactly, just unavailable, like a file you know exists on a server you can't currently reach. Someone asks you a question in a meeting and you know the answer but it takes a beat too long to surface. You lose the noun in the middle of the sentence. You read the same paragraph three times and it doesn't stick. And the thing that makes this specific kind of awful is that you know what your mind is capable of, because you experienced it last week.8 min readA brain that's slower than it used to be — the processing speed shiftIt's not that you can't remember things. You remember them. But the word that should be immediate has a half-second delay before it arrives — you can feel the gap, the small embarrassing pause while the noun catches up with the thought. A conversation that used to be effortless now requires more tracking. You're still following it, but you're working to follow it in a way you didn't used to notice. The work you could drop into and sustain for three hours now requires setup, and the flow state that used to arrive within minutes takes twenty, sometimes longer, sometimes doesn't fully arrive at all. You're producing the same output but it's costing more. You know you used to think faster, because you remember what it felt like when the thinking just ran.8 min readThe chronic low-grade headache pattern that lives behind your eyesIt's not a migraine. You know what a migraine is — or you've read enough to know this isn't that. It's not severe enough to stop you. It's not photophobic or accompanied by nausea most of the time. It doesn't put you in a dark room. It's just there: a low-grade pressure behind the eyes, or in the temples, or at the base of the skull where it meets the neck, and it's been there most days for long enough that you've started to think of it as your baseline. You manage through it. You take something for it. And the something helps for a few hours, and then it comes back, and you take something again, and the weeks pass.8 min readCortagen — the tetrapeptide for nerve recoveryPeripheral nerve injury has a particular quality of wrongness that distinguishes it from other kinds of physical damage. You break a bone and the path is clear — immobilize it, let it knit, follow the recovery protocol. You tear a muscle and the trajectory, while painful and slow, is well-established. Nerve damage is different. The numbness that won't resolve, the tingling that migrates, the weakness that shows up weeks after the initial injury and doesn't improve on a predictable schedule, the pain that arrives in the nerve's territory seemingly without cause — these don't follow the familiar repair arc. They follow a biology that the body runs slowly, incompletely, and in ways that medicine has limited tools to accelerate.7 min readWhat people are reporting about Cortexin for cognitive support and recoveryThis article summarizes experiences reported in public online communities including Reddit, longevity forums, and discussion boards. We are not advocating human use of any compound discussed here. Many of the peptides discussed are not FDA-approved for the uses described, and some are explicitly not approved for human or veterinary use. What follows is a synthesis of what people have reported, presented to give readers context on the public conversation — not as guidance, not as evidence of safety or efficacy, and not as a recommendation. Decisions about any compound should be made with a qualified prescribing provider after a full medical evaluation.8 min readCortexin in plain English — the bovine brain extract used in stroke recoveryYou survive the stroke. That part goes as well as it can — the clot is caught early, the emergency intervention works, you're alive and you go home. What no one prepares you for is the months afterward. The word that used to come in half a second now takes four. You lose the thread of a sentence mid-paragraph. You read the same line three times and it doesn't stay. The neurologist says you should be seeing improvement, that the brain is plastic, that recovery takes time — and all of that is true, and none of it tells you what to do about the fact that your thinking feels like it's running through wet concrete.8 min readCortexin for cognitive decline and recovery — what Eastern European research has exploredHe was fifty-three when the TBI happened. A car accident — nothing that looked catastrophic on the initial imaging, no bleeding that required surgery, discharged from the hospital within forty-eight hours with a list of follow-up appointments and instructions to rest. What nobody mentioned was that cognitive recovery from traumatic brain injury is not linear, is often incomplete, and has very few pharmacological tools backing it up in American medical practice. Three months later he was still struggling with processing speed, still losing words mid-sentence, still unable to hold complex work tasks together the way he used to. His neurologist offered reassurance and a referral to cognitive rehabilitation. That was the entire list.8 min readWhat people are reporting about DihexaThis article summarizes experiences reported in public online communities including Reddit, longevity forums, and discussion boards. We are not advocating human use of any compound discussed here. Many of the peptides discussed are not FDA-approved for the uses described, and some are explicitly not approved for human or veterinary use. What follows is a synthesis of what people have reported, presented to give readers context on the public conversation — not as guidance, not as evidence of safety or efficacy, and not as a recommendation. Decisions about any compound should be made with a qualified prescribing provider after a full medical evaluation.8 min readDihexa in plain English — the neurogenic peptide and the HGF/c-Met storyYou watch your father search for the word he used every day for forty years. He circles it, describes it, lands somewhere near it. The word itself is gone. That particular loss — not catastrophic, not dramatic, just the slow erosion of a mind that built things — is exactly the gap that a small group of neuropharmacologists in Pullman, Washington spent years trying to understand. Not to write a prescription. To understand what was happening at the level of the synapse, and whether it could be changed.8 min readFGL (FG loop) — the NCAM-derived peptide for memoryThere is a moment in some people's experience of early cognitive decline — not the dramatic loss, but the earlier and stranger one — when the brain begins to feel like a place where connections don't quite hold. You reach for a thought and find the thought, but the thread that leads to the next thought, and the one after that, is loose. Not broken. Just not as taut as it used to be. It is a subtle wrongness, and it is easy to dismiss. Doctors, when you describe it, sometimes tell you that stress does this. They are not wrong. They are also not entirely right.8 min readThe highly sensitive nervous system — when the world is louder than you can manageThe grocery store fluorescent lights are doing something specific to you. Not an annoyance — something more bodily than that, a low-grade physical wrong that most people in the same aisle don't seem to notice. The music in the restaurant is at a volume that makes conversation cost something. You leave a party that was objectively fine and you're not tired the way other people describe being tired — you're depleted at a different level, hollowed out in a way that takes a full day to undo. Someone near you is having a bad day and you can feel it before they say anything, in a way that doesn't feel metaphorical. Strong smells produce nausea. The scratchy tag in a shirt is a persistent distraction that others dismiss as background. You've been told your whole life, in various ways, that you are too much. Too sensitive. Too reactive. That you need to toughen up, that the world isn't going to turn its volume down for you.6 min readHumanin in Alzheimer's and neurodegenerative researchYou forget a name at a party and you're not sure whether it's nothing or the beginning of something. The forgetting itself isn't new — names have always been slippery — but the anxiety about the forgetting is new, and there's a quality to it that's different from forgetting where you put your keys. Keys have a logic to where they could be. A name you knew ten minutes ago has no logic to offer you. You stand there and there's just a gap, and the gap has a weight to it.8 min readThe kynurenine pathway — how chronic inflammation affects cognition and moodYou come down with a serious infection — flu, pneumonia, something that puts you in bed for a week. What nobody prepares you for is the cognitive and emotional texture of the illness: the flat affect, the inability to concentrate, the deep fatigue that feels different from ordinary tiredness, the mood that drops in ways a headache alone can't explain. You've been told this is your immune system fighting the infection. What you haven't been told is that a significant portion of what you're experiencing in your brain is a direct downstream consequence of what the immune system is doing to a single amino acid.6 min readLate-onset attention problems — adult ADHD that wasn't there at 25You used to be able to sit down and work. Not always effortlessly, but you could get in and stay in — a few hours of deep focus, a project moving, a real sense of completion at the end of the day. Now you sit down and something different happens. You open the document. A notification arrives. You check it. You check something adjacent to it. You return to the document and realize eight minutes have passed. You try again, drift again, and by noon you've produced a third of what you would have managed at 28 and you're carrying a low-grade shame about it that compounds across the week.5 min readThe midlife memory dip — what's normal, what isn'tYou walk into the kitchen and stop. You were coming in here for something. You stand there for a moment, trying to reverse-engineer the intention from the momentum, and it's gone. Later you're mid-sentence and the actor's name — you know this person, you've watched three of their movies — just isn't there. The sentence reroutes. You say "the guy from that film" and move on, but you notice. You notice it a lot now. And somewhere underneath the small daily embarrassments is a quieter, more persistent worry that you're not ready to say out loud.7 min readNeuroplasticity — what the brain actually does throughout lifeIn the 1960s, a neuroscientist named Michael Merzenich was doing something that most of his colleagues thought was pointless. He was mapping the cortex of monkeys — painstakingly recording which cortical neurons fired in response to stimulation of different fingers — and then watching what happened to those maps when he severed the nerve to one finger. The expectation, consistent with the dominant model of the adult brain, was that the cortical region representing the lost finger would go dark. Fall silent. Become an island of unused tissue. What he found instead was that within weeks, the surrounding finger representations had expanded into that territory. The brain had remapped itself. The adult brain was not fixed. It was actively reorganizing in response to peripheral input, and the reorganization happened at a scale and speed that the fixed-architecture model couldn't accommodate.8 min readIntranasal Orexin A for fatigue and cognitive performanceThe coffee isn't working. You've had two cups and you're waiting for something to shift — some brightening, some clearing of the cognitive fog — and the waiting itself feels like effort. This is a different kind of tired than the kind that comes from a late night or a hard workout. It's the low-arousal flatness that has been present for weeks, where the sleepiness isn't acute enough to justify going to bed at 2 p.m. but persistent enough that nothing feels quite sharp. Attention slides. Working memory drops things. The mental effort required for tasks that used to feel automatic has quietly doubled.6 min readOrexin A and the wakefulness system — narcolepsy and the inverse storyThe dog's name was Monty. He was a Doberman at the Stanford sleep laboratory, part of a colony that had been selectively bred for narcolepsy — sudden collapse into muscle paralysis, triggered by excitement or emotion, sometimes followed by what appeared to be dream-state episodes in an otherwise awake animal. Emmanuel Mignot had spent years trying to identify the genetic mutation responsible. The dogs offered a pure genetic model of narcolepsy. What Mignot found, after years of painstaking genetic work, changed the understanding of the condition entirely — and pointed toward a neurochemical system that nobody had yet described.6 min readThe oxytocin hype cycle — what the meta-analyses actually showedThe TED talk has been viewed several million times. The speaker describes oxytocin as the "moral molecule" — the chemical basis of empathy, of trust, of human goodness. He holds up the finding that a few puffs of intranasal oxytocin spray increase the money people entrust to strangers in an economic game, and he extrapolates to a vision of neurochemical kindness, of moral behavior bottled and delivered. The audience is charmed. The framing is elegant. And approximately a decade later, the careful second-wave replication literature has made the original claims look considerably more modest than that talk suggested.6 min readIntranasal oxytocin — what the social cognition research has exploredYou're in a conversation with someone you care about, but you can't quite access the warmth you know should be there. The words are right. The intent is there. But something is dialed down — some quality of felt connection, of being moved by the other person's presence — and you've been aware of it for months, maybe longer. It's most obvious at the moments when you want to feel close and instead feel like you're observing the closeness from a slight remove. You've chalked it up to stress, to the long workday, to the low-grade depletion that seems to have become baseline.7 min readP21 — the cell-penetrating peptide for neurogenesis and tumor targetingThe same peptide appears in two very different scientific conversations, and the confusion this creates is genuine and worth addressing directly. In one conversation, researchers are discussing how to kill cancer cells from the inside — how to smuggle a toxic payload through a malignant cell's membrane and disrupt the energy machinery that keeps it dividing. In another conversation, researchers are discussing how to encourage new neurons to grow in a brain damaged by age or disease, and how to restore the learning and memory function that depends on that growth. The compound at the center of both conversations is P21, also referred to in some literature as P021. It is not that the compound does only one of these things while the other is a mistake. The biological reality is stranger than that: the same small peptide has research arcs in both oncology and cognitive neuroscience, for reasons that become clearer when you understand what cell-penetrating peptides actually do.5 min readPACAP — the neuroprotective peptide also implicated in migraineIn 1989, Akira Arimura and colleagues at Tulane University were extracting ovine hypothalamic tissue — sheep brains, processed in quantity — looking for new signaling peptides. They were using an assay designed to detect compounds that elevated cyclic AMP in pituitary cells, a standard probe for peptides that activate adenylate cyclase. What they isolated was a thirty-eight amino acid neuropeptide, unlike anything previously characterized, that was among the most potent activators of adenylate cyclase in pituitary tissue they had ever encountered. They named it Pituitary Adenylate Cyclase-Activating Polypeptide. PACAP. The name was mechanistic rather than elegant, but it stuck.7 min readPACAP in migraine research — and the antibody drugs aimed at blocking itThe migraine starts the same way it always does. Not with pain — that comes later. It starts with a narrowing, a sense that the world is slightly too bright and the sounds slightly too present, and then the drilling begins somewhere behind one eye and the only thing that helps is a dark room and complete stillness and waiting for it to be over. You've tried the triptans. They work sometimes. You've tried the preventives — topiramate made you foggy, propranolol made you tired, amitriptyline was its own negotiation. The newer antibody drugs your neurologist mentioned are expensive, insurance coverage is inconsistent, and the waiting list at the headache clinic is four months.7 min readPE-22-28 — the short neuropeptide for mood, memory, and cognitive resilienceIt's two in the afternoon and you haven't started the thing you were supposed to start at nine. Not because you've been distracted — you've been sitting at the desk, roughly aimed at the work, just not doing it. The ceiling feels lower than usual. The inside of your head has a particular quality to it: not the sharp absence of sleep deprivation, not the flat numbness of serious depression, just a muted, frictionful kind of gray. You're functional. You're also, clearly, not at your best. And the standard advice — sleep, exercise, get some sunlight — is correct and insufficient.7 min readPeptides for cognition — what research has explored for focus, memory, and clarityYou sit down to work and the words on the screen won't stay still in your head. Not because you're tired — you slept. Not because you're distracted — the room is quiet. There's just a layer of gauze between you and the thing you're trying to think through. You reach for a thought and find most of it there, but not all of it. The edges are soft where they used to be sharp.10 min readPeptides for headache and migraine — beyond CGRP inhibitorsThe warning signs are specific enough by now that you know one is coming before it arrives. The light bothers you in a way that light doesn't normally bother you. There's a particular quality of tiredness, not the ordinary kind, that precedes the pain by a few hours. And then the pain itself — not a headache the way the word headache gets used casually, but a distinct biological event, unilateral, throbbing, frequently accompanied by nausea, and capable of disabling a full day or two with reliable consistency. You have tried things. Some of them work sometimes. None of them work always.10 min readPeptides for mood and depression — the research landscape beyond conventional antidepressantsIt doesn't always look like what you'd expect. Sometimes it's not the crying or the not getting out of bed. Sometimes it's the months where everything works technically — you show up, you perform, you answer emails — but there's a flatness underneath all of it that doesn't lift. Or it's the anhedonia: the things that used to matter just don't, not in a way you can explain to anyone who hasn't felt it. You mention it to your doctor and the conversation lasts eight minutes, ending with a prescription for an SSRI. You take it, maybe it helps some, maybe it helps enough, maybe it blunts the edges in ways that trade one problem for another. And you wonder, reasonably, whether there's more to understand about what's actually happening and whether there are other directions research has explored.10 min readPeptides for neurodegeneration prevention — what research has explored across Alzheimer's, Parkinson's, ALSYour father stopped recognizing you in his early seventies. Your mother is 68 and repeating herself in ways she dismisses as normal aging and that you're not sure about. You are 47. You have watched neurodegeneration from the inside of a family, which gives you a relationship to the question that no amount of general-population statistics can quite reach. You are not catastrophizing. You are paying attention, and you want to understand what, if anything, can be done with that attention before there is a clinical problem to manage.11 min readWhat people are reporting about PinealonThis article summarizes experiences reported in public online communities including Reddit, longevity forums, and discussion boards. We are not advocating human use of any compound discussed here. Many of the peptides discussed are not FDA-approved for the uses described, and some are explicitly not approved for human or veterinary use. What follows is a synthesis of what people have reported, presented to give readers context on the public conversation — not as guidance, not as evidence of safety or efficacy, and not as a recommendation. Decisions about any compound should be made with a qualified prescribing provider after a full medical evaluation.8 min readPinealon and the pineal gland — what a tripeptide bioregulator actually doesThere's a small organ buried deep in the center of your brain, roughly the size of a grain of rice, that Descartes called the seat of the soul. He was wrong about the metaphysics but not entirely wrong about the importance. The pineal gland sits at the junction of the two cerebral hemispheres, receives information about light through a neural pathway from the retina, and uses that information to synthesize and secrete melatonin — the hormone that tells the rest of your biology what time of day it is, what time of year it is, and when to shift into the physiological mode that sleep and cellular repair require. It is, in a meaningful sense, the body's master clock signal.7 min readPOTS and autonomic dysfunction — what your heart rate is telling youYou stand up from a chair and within minutes your heart is pounding at 140 beats per minute. You haven't done anything except change your vertical relationship to the floor. The lightheadedness comes first, then the racing pulse, then a heaviness behind your eyes that isn't quite a headache, and then — if you stay upright long enough — a greying at the edges of your vision that your body is clearly treating as an emergency even though you're standing in your kitchen. Lie back down. Within minutes, the heart rate falls. The fog begins to lift. Your body is, inexplicably, better on the floor than on your feet.9 min readPre-workout anxiety — when training starts feeling like fight-or-flightYou've been training for years. It's one of the things you do for yourself, one of the things that has reliably worked. And somewhere in the last year — not dramatically, not all at once — the warm-up has started feeling different. The first heavy set isn't anticipated the way it used to be. There's something closer to dread in it. Your heart rate is measurably elevated before the bar is even loaded. Your breathing is shorter than the exertion demands. The body is bracing instead of preparing, and you don't know when that switch happened.9 min readWhat people are reporting about SelankThis article summarizes experiences reported in public online communities including Reddit, longevity forums, and discussion boards. We are not advocating human use of any compound discussed here. Many of the peptides discussed are not FDA-approved for the uses described, and some are explicitly not approved for human or veterinary use. What follows is a synthesis of what people have reported, presented to give readers context on the public conversation — not as guidance, not as evidence of safety or efficacy, and not as a recommendation. Decisions about any compound should be made with a qualified prescribing provider after a full medical evaluation.8 min readSemax and Selank — the deeper history of Russian neuropeptide pharmacologyIn the early 1980s, inside a research institute attached to the Russian Academy of Sciences in Moscow, a team of peptide chemists was working on a problem that had preoccupied Soviet pharmacology for decades: how to modify naturally occurring peptide hormones into stable, pharmacologically useful drugs. The Institute of Molecular Genetics was not primarily a clinical institution. It was a molecular biology research center, and its interest in neuropeptides was fundamentally mechanistic — these researchers wanted to understand how small peptide fragments derived from larger hormones could influence brain function in targeted and lasting ways. What they produced, over roughly a decade of synthetic chemistry and biological testing, became Semax and Selank: two synthetic neuropeptides that entered Russian clinical practice in the 1990s and have remained part of the Russian pharmacological landscape ever since.10 min readWhat people are reporting about SemaxThis article summarizes experiences reported in public online communities including Reddit, longevity forums, and discussion boards. We are not advocating human use of any compound discussed here. Many of the peptides discussed are not FDA-approved for the uses described, and some are explicitly not approved for human or veterinary use. What follows is a synthesis of what people have reported, presented to give readers context on the public conversation — not as guidance, not as evidence of safety or efficacy, and not as a recommendation. Decisions about any compound should be made with a qualified prescribing provider after a full medical evaluation.8 min readSemax, Selank, and the calm-focus questionYou've tried the stimulant route. The first week was productive — maybe genuinely productive — and then the jitteriness settled in, the appetite disappeared, and the crash at 4 p.m. made the second half of the day feel like a tax you owed. You've tried the other route too: the SSRI that took the edge off everything, including the part of you that cared about getting things done. Somewhere between wired and flat there's a thing you're looking for, and it doesn't seem to have a name.8 min readRestaurants used to be fine — when noise processing changesYou used to enjoy a busy restaurant. The noise was part of it — the hum of other conversations, the kitchen sounds, the social density of a room where everyone had somewhere to be. Now you sit down in that same kind of room and something is different. Following the conversation across the table requires an effort that didn't use to be required. You find yourself leaning in more, concentrating harder, asking people to repeat things. By the time the main course arrives you're running a low-level effort expenditure that has nothing to do with the food or the company. By the end of the evening you're tired in a way that can't quite be attributed to the late hour.8 min readCan't quite find the word — when retrieval became effortYou're mid-sentence and the noun isn't there. You know exactly what you mean. The shape of the word is present — you can feel its weight, its approximate sound, the number of syllables — but the word itself has retreated behind something and won't come forward. The sentence pauses. Or reroutes: you produce a circumlocution, a similar-but-adjacent word, a gesture toward meaning that your listener follows while you internally register that the word should have been there. Conversation continues. But you noticed. And you've been noticing more often. And the noticing has acquired a faint edge of anxiety that the word-finding difficulty itself doesn't quite justify.8 min readThe headache after screens — what your after-work temple pain is signalingBy four in the afternoon there's a dull pressure starting at your temples, the kind that feels like it's coming from just behind the eyes and slowly tightening a band across the front of your head. The eyes themselves are dry and faintly burning, gritty when you blink, and the screen you've stared at through six hours of video calls and documents has taken on a slightly swimmy quality that makes you want to rub them. You close the laptop at the end of the day and the headache doesn't close with it — it rides home with you, settling in for the evening, a small tax levied for the work you just did with your eyes.8 min readThe mood that's flat, not sad — when depression doesn't quite fitYou're not sad exactly. There's no event that explains it, no loss you're processing, no acute thing you can point to and say: that's why. Life is fine by every external measure — the job functions, the relationships are intact, there's nothing wrong. But somewhere in the last year or two, color has gone out of things. The meal at the restaurant you've been wanting to try is good but it doesn't quite land the way a meal like that used to. Music that used to move you plays and you register that it's good without feeling it. You accomplish something you worked toward and there's a moment of mild satisfaction that doesn't build to anything. Sex happens but the wanting is muted. You're going through the motions of a life that still works but you're not quite inside it.8 min readThe tinnitus that arrived quietly — what the constant ringing might meanIt wasn't there a year ago. Or if it was, it wasn't this — it was something you could lose in a crowd, in a conversation, in anything louder than silence. Now it's in the quiet rooms. The moment you turn the TV off. The space before sleep, which used to be peaceful and is now occupied by a high-frequency tone that sits somewhere between a hiss and a ring, sometimes in one ear, sometimes in both, sometimes shifting and sometimes fixed. When you're stressed it gets louder. You've started leaving a fan on at night because silence has a sound in it that you didn't ask for. You mention it at your appointment and they ask if you've been to concerts, if you've used power tools. You say yes, some, years ago. They say that's probably it. You leave with nothing else.8 min readThe vertigo spells you can't explainIt comes without warning, or it comes when you turn a certain way — roll over in bed, look up at a high shelf, turn your head quickly to the right. The room tilts. Not metaphorically. The room actually tilts, spinning or shifting in a way that has no relationship to any movement you've made, and for a few seconds or a few minutes the floor is unreliable. Sometimes there's nausea. Sometimes there's a cold sweat. Sometimes it passes in thirty seconds and you're left standing very still, waiting to be sure it's over. Sometimes it doesn't pass quickly and you end up sitting on the floor of a grocery store waiting for the world to settle. You describe this to your doctor and they say it sounds like benign positional vertigo, give you a handout about the Epley maneuver, and that's the end of it.8 min readThe vagus nerve, deeper — afferents, the inflammatory reflex, and the polyvagal debateIn 1998, an immunologist named Kevin Tracey was testing an experimental anti-inflammatory drug in the brains of rats, expecting it to act only inside the skull. Instead, when he injected the compound into the brain, inflammation dropped throughout the body, far from the injection site, and faster than any blood-borne signal could have traveled. The result made no sense under the prevailing model, in which inflammation was governed by molecules diffusing through the bloodstream. Tracey reasoned that something faster than chemistry must be carrying the message — something electrical. He cut the vagus nerve in the rats, repeated the experiment, and the anti-inflammatory effect vanished. The brain had been using the vagus nerve as a wire to switch off inflammation in the body. That single experiment opened a field, and it is the right place to begin a deeper look at a nerve most people think they already understand.8 min readThe vagus nerve — the wandering nerve that connects everythingIn 1921, a German pharmacologist named Otto Loewi woke from a dream, scrawled something on a notepad, went back to sleep, and woke again to find his own handwriting unreadable. The next night the dream returned and this time he went immediately to his laboratory. He took two frog hearts, kept both beating in saline solution, and stimulated the vagus nerve of one. That heart slowed down. He then transferred the saline fluid to the second heart and it also slowed — without any nerve stimulation at all. Something chemical had been released by vagal stimulation. That chemical was acetylcholine, the first neurotransmitter identified in the human body. The experiment won Loewi the Nobel Prize in 1936, and it established, at the cellular level, what the vagus nerve actually does: it releases a molecule that slows the heart.11 min read